Health · 1 sources covering this

STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/af6ce49b12075470282e9f9687efeb26998e24e4"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation"></iframe>

STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

How 1 sources are covering this

STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

More from Health

The copper peptide trend has gone from creams to injections — ahead of the science

The copper peptide trend has gone from creams to injections — ahead of the science

Pig kidneys keep patients alive long enough to get human kidneys for the first time

STAT+: Not so fast: Diabetes association panel not done reviewing ejections from its June meeting

Reader

Trust & legal

Across the network